Annual Cash & Cash Equivalents
$167.30 M
-$129.30 M-43.59%
31 December 2023
Summary:
Cytek Biosciences annual cash & cash equivalents is currently $167.30 million, with the most recent change of -$129.30 million (-43.59%) on 31 December 2023. During the last 3 years, it has risen by +$2.07 million (+1.25%). CTKB annual cash & cash equivalents is now -54.12% below its all-time high of $364.62 million, reached on 31 December 2021.CTKB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$162.27 M
-$15.62 M-8.78%
30 September 2024
Summary:
Cytek Biosciences quarterly cash and cash equivalents is currently $162.27 million, with the most recent change of -$15.62 million (-8.78%) on 30 September 2024. Over the past year, it has dropped by -$1.36 million (-0.83%). CTKB quarterly cash and cash equivalents is now -56.93% below its all-time high of $376.77 million, reached on 30 September 2021.CTKB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.6% | -0.8% |
| 3 y3 years | +1.3% | -56.9% |
| 5 y5 years | - | - |
CTKB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.1% | +1.3% | -56.9% | +25.3% |
| 5 y | 5 years | -54.1% | +455.4% | -56.9% | +25.3% |
| alltime | all time | -54.1% | +455.4% | -56.9% | +25.3% |
Cytek Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $162.27 M(-8.8%) |
| June 2024 | - | $177.89 M(+5.4%) |
| Mar 2024 | - | $168.79 M(+0.9%) |
| Dec 2023 | $167.30 M(-43.6%) | $167.30 M(+2.2%) |
| Sept 2023 | - | $163.63 M(+24.4%) |
| June 2023 | - | $131.54 M(+1.6%) |
| Mar 2023 | - | $129.48 M(-56.3%) |
| Dec 2022 | $296.60 M | $296.60 M(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $341.52 M(-2.4%) |
| June 2022 | - | $349.89 M(-3.5%) |
| Mar 2022 | - | $362.51 M(-0.6%) |
| Dec 2021 | $364.62 M(+120.7%) | $364.62 M(-3.2%) |
| Sept 2021 | - | $376.77 M(+135.7%) |
| June 2021 | - | $159.85 M(-5.2%) |
| Mar 2021 | - | $168.58 M(+2.0%) |
| Dec 2020 | $165.23 M(+448.5%) | $165.23 M |
| Dec 2019 | $30.12 M | - |
FAQ
- What is Cytek Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cytek Biosciences?
- What is Cytek Biosciences annual cash & cash equivalents year-on-year change?
- What is Cytek Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cytek Biosciences?
- What is Cytek Biosciences quarterly cash and cash equivalents year-on-year change?
What is Cytek Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CTKB is $167.30 M
What is the all time high annual cash & cash equivalents for Cytek Biosciences?
Cytek Biosciences all-time high annual cash & cash equivalents is $364.62 M
What is Cytek Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, CTKB annual cash & cash equivalents has changed by -$129.30 M (-43.59%)
What is Cytek Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CTKB is $162.27 M
What is the all time high quarterly cash and cash equivalents for Cytek Biosciences?
Cytek Biosciences all-time high quarterly cash and cash equivalents is $376.77 M
What is Cytek Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, CTKB quarterly cash and cash equivalents has changed by -$1.36 M (-0.83%)